SEARCH:
Print Text size Comment
Email this
Clinical Trials Update: Nov. 5, 2009

The form has errors highlighted in red, please review these entries and try again!



(Separate multiple addresses with commas)




privacy policy | visitor agreement

Clinical Trials Update: Nov. 5, 2009



HealthDay News

Thursday, November 05, 2009

(HealthDayNews) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Ulcerative Colitis

This study will evaluate the effectiveness and safety of an investigational medication in people with active mild-or-moderate ulcerative colitis.

The research site is in Los Angeles, Calif.

More Information

Please see clinicalconnection.com/clinical_trials/condition/ulcerative_colitis.aspx.

-----

Weight Loss (Ages 18-60)

This study will evaluate an investigational drug for weight loss.

The research site is in Baltimore, Md.

More Information

Please see clinicalconnection.com/clinical_trials/condition/weight_loss.aspx.

-----

Pediatric Depression

This study will evaluate the investigational use of an approved medication to see if it reduces symptoms of depression in people aged 7 to 17.

The research site is in Seattle, Wash.

More Information

Please see clinicalconnection.com/clinical_trials/condition/depression.aspx.

-----

Copyright 2009 ClinicalConnection.com. All rights reserved.

INSIDE LIFE & MARQUEE

Church Notes
Faith and fellowship

Calendar follows local congregations' many activities.


Over 6 million items at your fingertips! Enter a keyword or highlight a category to search or browse at your leisure!
Search by Category

Rocky Mount Telegram | Weather | Sports | Life | Business News | Opinions | Classifieds | Sitemap
Rocky Mount Cars | Rocky Mount Jobs | Rocky Mount Real Estate

Copyright 2009 Rocky Mount Telegram All rights reserved. - Rocky Mount Telegram - Our Partners

By using this service, you accept the terms of our visitor agreement and privacy policy. About our ads.
Registered site users, you may edit your profile.
Having trouble? Visit our help & FAQ